In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Predictors of Residual Anterior Circulation Aneurysm Filling Following Flow Diversion Embolization

    Final Number:
    323

    Authors:
    Robert Scranton MD; Yi Jonathan Zhang MD; Gavin W. Britz MD; Orlando Diaz MD; Richard Klucznik MD

    Study Design:
    Other

    Subject Category:
    Aneurysm/Subarachnoid Hemorrhage

    Meeting: AANS/CNS Cerebrovascular Section 2016 Annual Meeting

    Introduction: Flow diversion (FD) procedures for intracranial aneurysms uses a stent with an increased surface area for embolization. Protection from aneurysmal rupture is gradual and follow-up imaging is indicated until the aneurysm is occluded. Multiple series have reported incomplete occlusion at six months requiring further observation or treatment. This series analyzes our outcomes and factors associated with residual anterior circulation aneurysms six months following FD.

    Methods: Retrospective review of all anterior circulation aneurysms FD procedures at our facility from 5/11-1/14 with six month radiographic follow-up. Treatment data included: presentation, number of aneurysms, location, size, morphology, procedural duration, complications, number of FD, and adjunct devices. Patient characteristics: age, sex, BMI, medical comorbidities, smoking history and coagulation profile. Cases with dissections, dissecting aneurysms, pseudoaneurysms and incomplete follow-up were excluded. Data was analyzed by stepwise logistic regression using MedCalc Statistical Software (Ostend, Belgium).

    Results: Fifty-three patients met inclusion criteria with 71 aneurysms treated with 58 FDs. The most common aneurysm was ophthalmic segment (40%) and 26% of patients had multiple aneurysms treated by the same device (or devices with overlap for long segments, 3 patients). Sixteen of 53 patients had residual filling at 6 months. No factor reached significance at P<0.05 for residual filling at 6 months. Presence of multiple aneurysms in the treatment segment reached significance at P=0.057, Odds Ratio 2.3 (0.9560 to 5.7959, 95% CI).

    Conclusions: This series examined patient, anatomic, and procedural data to identify elements associated with residual aneurysm filling 6 months after FD. The presence of multiple aneurysms showed a strong trend towards significance (P=0.057, Odds Ratio 2.3), where 43% of those with multiple aneurysms had residual filling in this series. No element reached significance at P<0.05. Further research is needed with computational fluid dynamics to determine how multiple aneurysms effect FD related changes and residual filling compared to single aneurysms.

    Patient Care: This project helps to identify possible risk factors for treatment failure after flow diversion and patients who may require increased monitoring or further treatment.

    Learning Objectives: By the conclusion of this session participants should be able to: 1. Describe factors thought to be associated with flow diversion treatment failure at 6 months. 2. Understand the importance of continued monitoring following flow diversion. 3. Discuss future directions in investigating treatment efficacy of flow diversion.

    References: 1. O'Kelly CJ, Spears J, Chow M, et al. Canadian experience with the pipeline embolization device for repair of unruptured intracranial aneurysms. AJNR Am J Neuroradiol. 2012;34(2):381–387. doi:10.3174/ajnr.A3224. 2. Murthy SB, Shah S, Shastri A, Rao CPV, Bershad EM, Suarez JI. The SILK flow diverter in the treatment of intracranial aneurysms. J Clin Neurosci. 2013;21(2):203–206. doi:10.1016/j.jocn.2013.07.006. 3. De Vries J, Boogaarts J, Van Norden A, Wakhloo AK. New generation of Flow Diverter (surpass) for unruptured intracranial aneurysms: a prospective single-center study in 37 patients. Stroke. 2013;44(6):1567–1577. doi:10.1161/STROKEAHA.111.000434. 4. Becske T, Kallmes DF, Saatci I, et al. Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial. Radiology. 2013;267(3):858–868. doi:10.1148/radiol.13120099.

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy